Neuroprotective Effects of Collagen-Glycosaminoglycan Matrix Implantation following Surgical Brain Injury

Figure 5

Changes in cytokine concentrations within brain tissue in the treatment groups. (a) Granulocyte-macrophage colony-stimulating factor (GMCSF), (b) interleukin-10 (IL-10), (c) tumor necrosis factor-alpha (TNF-α), (d) IL-6, and (e) NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) protein concentration as measured by ELISA in the brain tissue from the sham (SHAM), surgery-induced brain lesion (L), and collagen-glycosaminoglycan matrix implantation following surgery-induced lesion cavity (L+CG) groups. Data are presented as the . , , and vs. the SHAM group; , , and vs. the L+CG group.

(a)

(b)

(c)

(d)

(e)